Cargando…
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records
Pharmacogenomics aims to tailor pharmacological treatment to each individual by considering associations between genetic polymorphisms and adverse drug effects (ADEs). With technological advances, pharmacogenomic research has evolved from candidate gene analyses to genome-wide association studies. H...
Autores principales: | Tasa, Tõnis, Krebs, Kristi, Kals, Mart, Mägi, Reedik, Lauschke, Volker M., Haller, Toomas, Puurand, Tarmo, Remm, Maido, Esko, Tõnu, Metspalu, Andres, Vilo, Jaak, Milani, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460570/ https://www.ncbi.nlm.nih.gov/pubmed/30420678 http://dx.doi.org/10.1038/s41431-018-0300-6 |
Ejemplares similares
-
Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions
por: Reisberg, Sulev, et al.
Publicado: (2018) -
RegScan: a GWAS tool for quick estimation of allele effects on continuous traits and their combinations
por: Haller, Toomas, et al.
Publicado: (2015) -
Differences in local population history at the finest level: the case of the Estonian population
por: Pankratov, Vasili, et al.
Publicado: (2020) -
A human-specific VNTR in the TRIB3 promoter causes gene expression variation between individuals
por: Örd, Tiit, et al.
Publicado: (2020) -
DOCEST—fast and accurate estimator of human NGS sequencing depth and error rate
por: Kaplinski, Lauris, et al.
Publicado: (2023)